Source: Eur Respir J 2013; 41: 31-38
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Carter Richard I., Ungurs Michael J., Mumford Richard A., Stockley Robert A.. A?-Val360: a marker of neutrophil elastase and COPD disease activity. Eur Respir J 2013; 41: 31-38

Member's Comments

No comment yet.

Related content which might interest you: Neutrophil elastase levels is higher in patients with lung cancer than chronic obstructive pulmonary disease Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Proteinase 3 activity in sputum from subjects with alpha-1-antitrypsin deficiency and COPD Source: Eur Respir J 2013; 41: 1042-1050 Year: 2013 Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1 Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Matrix metalloproteinases and lung disease severity in chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 249s Year: 2001 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Airway neutrophilia in COPD is not associated with increased neutrophil survival Source: Eur Respir J 2006; 28: 1163-1169 Year: 2006 Desmosin as a marker for tissue injury in COPD Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news Year: 2007 Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2005 - Systemic effects of COPD Year: 2005 Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 612-617 Year: 2005 Can mean platelet volume be an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease? Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Polymorphonuclear elastasa and collagenasa activity in patients with chronic obstructive pulmonary disease and acute bronchities Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Clinical value of C-reactive protein in severe acute exacerbations of COPD Source: Annual Congress 2005 - COPD - acute exacerbations Year: 2005 Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations Source: Annual Congress 2005 - COPD: role of infection Year: 2005 Increased neutrophil gelatinase-associated lipocalin (NGAL) promotes airway remodeling in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Characterization of elastin degradation biomarkers in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020